Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
The VEGF-A165 (pro-angiogenic) and VEGF-A165b (anti-angiogenic), only the sequence of 6 amino acid residues of the C- terminal side is different. The current ELISA system of VEGF-A does not discriminate between different VEGF-A isoforms (pro- or anti-angiogenic forms). Here, we made the development of VEGF-A165b specific ELISA system, and the clarified the molecular mechanisms of VEGF-A165b. Moreover, the urinary VEGF-A165b concentration was found to be useful for the development assessment of renal dysfunction.
|